Search
for
Sort by
Research 121–150 of 217
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Nanotechnology-Driven Delivery of Caffeine Using Ultradeformable Liposomes-Coated Hollow Mesoporous Silica Nanoparticles for Enhanced Follicular Delivery and Treatment of Androgenetic Alopecia
- Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature
- [Protective effects of coenzyme Q10 on the adverse reactions of anthracycline antibiotics: using double blind method--with special reference to hair loss].
- Scalp cooling in the prevention of anthracycline-induced alopecia
- Role of liposomal anthracyclines in the treatment of multiple myeloma
- Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
- Safety and efficacy of low-dose metronomic cyclophosphamide plus vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
- Management of Chemotherapy-Induced Alopecia With Scalp Cooling
- Abstract P3-09-15: Permanent chemotherapy induced alopecia in early breast cancer patients after (neo)adjuvant chemotherapy: Long term follow up
- Efficacy of Scalp Cooling in the Prevention of Chemotherapy Induced Alopecia Among Breast Cancer Patients
- Objective quantification of chemotherapy-induced madarosis: a pilot study of an automated computer vision pipeline for eyebrow density assessment
- Clinical and genetic predictors of persistent chemotherapy-induced alopecia despite scalp cooling in breast cancer
- Scalp cooling therapy for chemotherapy-induced hair loss in Asian patients with breast or gynecological cancers – a tertiary institution experience
- Care for alopecia during chemotherapy of cancer patients
- Topoisomerase‐Interacting Agents
- [A patient with advanced recurrent breast cancer who firmly resisted hair loss and was then treated by combination therapy with high-dose toremifene and capecitabine].
- Patient-reported Outcomes of Adverse Events After Perioperative Chemotherapy for Breast Cancer: A Prospective Observational Study
- Arsenic Trioxide as Effective Therapy for Relapsed Acute Promyelocytic Leukemia
- Mitoxantrone
- Mitoxantrone, Etoposide and Prednisolone—a Novel Combination in The Treatment of Relapsed and Refractory Lymphoma
- Patient-reported outcomes of adverse events after perioperative chemotherapy for breast cancer: A prospective observational study
- Development of PEGylated Liposomes
- Clinical Development of Topoisomerase-Interactive Drugs
- Clinical and histological study of permanent alopecia after bone marrow transplantation
- Mucocutaneous reactions to chemotherapy
- Cutaneous complications of chemotherapeutic agents
- Drug-Induced Skin, Nail and Hair Disorders
- Protection Against Chemotherapy-Induced Alopecia
- Adverse effects of common medications on male fertility